Lata Singh1, Neeru Saini2, Neelam Pushker3, Seema Sen1, Anjana Sharma4, Seema Kashyap5. 1. Department of Ocular Pathology, Dr. R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. 2. Functional Genomics Unit, Institute of Genomics and Integrative Biology, Mall Road, New Delhi, India. 3. Department of Ophthalmology, Dr. R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. 4. Department of Ocular Microbiology, Dr. R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. 5. Department of Ocular Pathology, Dr. R.P. Centre for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, India. dr_skashyap@hotmail.com.
Abstract
BACKGROUND: Reactive oxygen species (ROS) have been shown to enhance the proliferation of cancer cells. NADPH oxidases (NOX4) are a major intracellular source of ROS and are found to be associated with cancer and tumor cell invasion. Therefore, the purpose of this study is to evaluate the expression of NOX4 protein in human retinoblastoma. METHODS: Immunohistochemical expression of NOX4 protein was analyzed in 109 specimens from prospective cases of retinoblastoma and then correlated with clinicopathological parameters and patient survival. Western blotting confirmed and validated the immunoreactivity of NOX4 protein. RESULTS: In our study we found a male preponderance (55.9 %), and 25/109 (22.9 %) were bilateral. Massive choroidal invasion was the histopathological high-risk factor (HRF) most frequently observed, in 42.2 % of the cases. NOX4 protein was expressed in 67.88 % (74/109) of primary retinoblastoma cases and was confirmed by Western blotting. NOX4 was statistically significant with massive choroidal invasion and pathological TNM staging. There was a statistically significant difference in overall survival in patients with NOX4 expression (p = 0.0461). CONCLUSION: This is the first study to show the expression of NOX4 protein in retinoblastoma tumors. Hence, a retinoblastoma tumor may exhibit greater ROS stress. This protein may prove to be useful as a future therapeutic target for improving the management of retinoblastoma.
BACKGROUND:Reactive oxygen species (ROS) have been shown to enhance the proliferation of cancer cells. NADPH oxidases (NOX4) are a major intracellular source of ROS and are found to be associated with cancer and tumor cell invasion. Therefore, the purpose of this study is to evaluate the expression of NOX4 protein in humanretinoblastoma. METHODS: Immunohistochemical expression of NOX4 protein was analyzed in 109 specimens from prospective cases of retinoblastoma and then correlated with clinicopathological parameters and patient survival. Western blotting confirmed and validated the immunoreactivity of NOX4 protein. RESULTS: In our study we found a male preponderance (55.9 %), and 25/109 (22.9 %) were bilateral. Massive choroidal invasion was the histopathological high-risk factor (HRF) most frequently observed, in 42.2 % of the cases. NOX4 protein was expressed in 67.88 % (74/109) of primary retinoblastoma cases and was confirmed by Western blotting. NOX4 was statistically significant with massive choroidal invasion and pathological TNM staging. There was a statistically significant difference in overall survival in patients with NOX4 expression (p = 0.0461). CONCLUSION: This is the first study to show the expression of NOX4 protein in retinoblastoma tumors. Hence, a retinoblastoma tumor may exhibit greater ROS stress. This protein may prove to be useful as a future therapeutic target for improving the management of retinoblastoma.
Authors: T Mochizuki; S Furuta; J Mitsushita; W H Shang; M Ito; Y Yokoo; M Yamaura; S Ishizone; J Nakayama; A Konagai; K Hirose; K Kiyosawa; T Kamata Journal: Oncogene Date: 2006-03-13 Impact factor: 9.867
Authors: Agnes Juhasz; Yun Ge; Susan Markel; Alice Chiu; Linda Matsumoto; Josephus van Balgooy; Krishnendu Roy; James H Doroshow Journal: Free Radic Res Date: 2009-06
Authors: Sebastian Altenhöfer; Pamela W M Kleikers; Kim A Radermacher; Peter Scheurer; J J Rob Hermans; Paul Schiffers; Heidi Ho; Kirstin Wingler; Harald H H W Schmidt Journal: Cell Mol Life Sci Date: 2012-05-31 Impact factor: 9.261
Authors: Álvaro Santana-Garrido; Claudia Reyes-Goya; Carmen Fernández-Bobadilla; Antonio J Blanca; Helder André; Alfonso Mate; Carmen M Vázquez Journal: Mol Vis Date: 2021-04-02 Impact factor: 2.367